WELLINGTON MANAGEMENT GROUP LLP
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 902219
Boston, MA
Position in IRWD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,591,836
-$106,448 QoQ
Shares Held
453,515
-10.0% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 70.62390439125498.ToString("F0")%
None 29.376095608745022.ToString("F0")%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. IRWD ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,264,247 | $1,342,653,181 | |
| 2 | ZTS |
Zoetis Inc.
|
10,150,096 | $1,199,842,846 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,251,828 | $218,425,057 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,389,539 | $183,057,866 | |
| 5 | ALKS |
Alkermes plc.
|
2,970,166 | $105,025,067 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,035,856 | $72,648,032 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
768,850 | $58,317,270 | |
| 8 | HLN |
Haleon plc
|
4,828,648 | $48,334,765 |
All Filings in IRWD
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,591,836 | 453,515 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,698,284 | 503,942 | Shares | Defined | 2026-02-17 | |
| 2024-06-30 | $713,905 | 109,495 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $828,267 | 95,094 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,114,461 | 97,418 | Shares | Defined | 2024-02-12 | |
| 2023-03-31 | $64,997,167 | 6,178,438 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $165,287,270 | 13,340,377 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $143,569,593 | 13,858,069 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $172,004,008 | 14,917,954 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $190,985,117 | 15,181,647 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $201,721,554 | 17,300,305 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $228,563,331 | 17,501,021 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $271,488,154 | 21,094,651 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $236,896,427 | 21,189,305 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $246,225,749 | 21,617,713 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $200,253,630 | 22,275,154 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $229,298,622 | 22,218,859 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $222,628,482 | 22,064,270 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||